Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.

Novo Nordisk’s practices have raised red flags in Denmark as well as in the US and UK for years, with the more recent ones ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

What led to the muted performance in the generics business? Generics revenue was Rs 624 crore, a decline of 8% YoY, ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...